ASGE Recognized Industry Associate (ARIA) Training Program OPEN | October 2026-Day in the Life of a Gastroenterologist- Interactive Discussion with the Faculty (Part II of II)

Day in the Life of a Gastroenterologist- Interactive Discussion with the Faculty (Part II of II)

Video Transcription

Video Summary

The gastroenterology panel answered questions about clinical practice, technology, and industry collaboration. They said long-term proton pump inhibitor use is generally safe when medically indicated, though patients who no longer need PPIs should be encouraged to stop them.<br /><br />For industry representatives, the panel recommended researching clinicians’ specialties and preferences, understanding their products in depth, respecting busy clinical settings, and building relationships over time. They highlighted advances that have changed care, including therapeutic endoscopic ultrasound, improved stents and imaging, and expanding treatments for inflammatory bowel disease.<br /><br />The panel described single-use scopes as a potential option in select situations but said their role remains uncertain given cost, waste, and improvements in reprocessing. They noted that the causes of rising colorectal cancer rates among younger adults are still unclear, underscoring the need for better risk stratification and research. Endoscopic removal can preserve organs for some cancers, but surgery remains necessary when disease has invaded too deeply; improving referrals and access to advanced expertise is important.<br /><br />Other topics included pediatric Crohn’s disease, rapidly evolving obesity treatments such as GLP-1 medications, and the future potential of endoluminal robotics. Robotics would need to improve efficiency, reduce fatigue, and prove safe and cost-effective. Screening colonoscopies are generally diagnostic and therapeutic, with most polyps removed during the same procedure.

Keywords

gastroenterology

proton pump inhibitors

endoscopic ultrasound

single-use scopes

colorectal cancer

inflammatory bowel disease

endoluminal robotics